/ With cancer projected to escalate to 29 million cases by 2040[1], Novigenix, a pioneer in AI healthcare solutions, is rewriting the rules of cancer care. Their newest innovation, LITOSeek™, is primed to reshape drug development, offering a transformative leap
Trending
- MEAPMP Launches: Revamped Independent Ad-Tech & Premium Media Buying Across MEA
- Sam Altman calls UAE most forward-looking country on AI
- OpenAI deals bring frontier AI to ADNOC and Abu Dhabi Government
- Indonesia posts $10.6 billion trade surplus on non-oil exports
- Africa’s top banks build war chest for Kenya takeover deals
- Sheikh Mohamed receives Markus Söder to boost UAE-Bavaria ties
- Chervon Names Jody Grimsley Senior National Account Manager
- Apple iPhone Duo sets a new benchmark for foldable design

